QbD Group
    即将举办的网络研讨会

    AI in Life Sciences: Session 2, Your Questions Answered

    Adopting AI in life sciences holds enormous potential, but navigating GxP requirements adds real complexity. In this joint session, QbD Group and delaware walk you through how to deploy AI that is trustworthy, validated, and inspection-ready, covering data governance, explainability, and lifecycle management. Building on the first session, this edition dedicates more time to answering your questions, addressing the topics raised by the audience in Session 1, and opening the floor for live debate and discussion.

    2026年5月13日星期三
    3 PM CEST / 1 PM GMT
    Software Solutions & Services
    Chinese

    Implement AI faster without losing compliance

    AI is reshaping digital operations across life sciences. Yet deploying AI within a GxP-regulated environment brings distinct risks, particularly when data is distributed across disparate systems and workflows.

    Without solid foundations, organizations encounter hurdles such as fragmented data, gaps in audit trails, and limited traceability. Model transparency and explainability are also drawing increased regulatory attention during inspections. Moreover, because AI models continuously evolve, a structured lifecycle management strategy, aligned with CSA principles, is indispensable.

    This session covers the same core presentation as Session 1, but with a different focus: your questions take center stage. Rather than a one-way walkthrough, this is an open, interactive session built around debate, discussion, and answering the questions already raised in Session 1, as well as new ones from the live audience. If you attended the first session and left with unanswered questions, or if you're joining for the first time and want a more conversational format, this is the session for you.

    QbD Group and delaware present how their combined strengths deliver a pragmatic, integrated, and validated approach to AI adoption in regulated life sciences settings, helping you transition from proof-of-concept to compliant deployment with confidence.

    What you'll learn

    • Best practices for AI implementation under GxP
    • How to avoid common pitfalls, such as:
      • Poor quality or insufficiently governed training and validation data
      • Deploying black-box models with low explainability
      • Applying insufficient governance and controls
    • Insights into our joint framework methodology for compliant AI
    • Real-world examples where innovation meets compliance
    • Answers to your questions, both those raised in Session 1 and new ones submitted live

    About the hosts

    QbD Group partners with life sciences organizations across the globe to uphold the highest quality and safety standards, from concept to patient, leveraging expertise in quality assurance, regulatory compliance, clinical services, and digital solutions.

    delaware is a global consultancy and SAP Platinum Partner that helps organizations navigate business and digital transformation through comprehensive IT and enterprise technology solutions.

    Together, we enable life sciences companies to close the gap between technology and compliance, making sure every digital initiative is validated, inspection-ready, and future-proof from the start.

    Our support

    Our expertise in software implementation, validation, and IT partnerships bridges the gap between regulatory requirements, business processes, and technology. Whether you want to modernize workflows, enhance data utilization, or future-proof your systems, we guide you every step of the way.

    向最优秀的人学习

    演讲者

    Hear from industry experts who bring hands-on experience in implementing and validating systems in GxP-regulated environments.

    Jonathan Boel

    Jonathan Boel

    Division Head Software Solutions & Services at QbD Group

    Jonathan co-leads the Quality Assurance and Software Solutions & Services divisions at QbD Group. He is a CSV (Computer System Validation) expert who drives digital transformation and technology-enabled compliance solutions for the life sciences industry, including QbD's cloud-based pre-validated QMS and eIFU services.

    Evelien Cools

    Evelien Cools

    Industry Lead Life Sciences at delaware

    Industry Lead Life Sciences at delaware, guiding customers in digital transformation from molecule to market. Specializes in elevating operational processes to best-in-class practices with strategic and pragmatic implementation approaches.

    Pieter Smits

    Pieter Smits

    Project Manager at QbD Group

    Pieter is a Project Manager at QbD Group, coordinating multi-disciplinary teams to deliver quality and regulatory consulting projects.

    Starts in

    42Days
    21Hours
    05Min
    25Sec

    Register here

    Is this for you?

    Who should attend?

    This webinar is tailored for professionals working in the Pharmaceutical, Biotech, and MedTech sectors, including: Learn from our experts

    IT & Digital Transformation Leaders

    Quality & Compliance Experts (QA, CSV, RA, IT)

    AI enthusiasts who want to go from proof-of-concept to implementation

    Anyone who attended Session 1 and wants their questions answered, or who prefers a more interactive format

    Keep watching

    More webinars

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development 点播网络研讨会

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development

    Regulatory Affairs2026年3月18日

    Early-stage biotech teams often struggle to translate scientific innovation into first-in-human readiness. This webinar provides practical guidance to help teams build a clear, scalable development pathway that aligns regulatory strategy, CMC, quality, and clinical planning. Reducing risk, avoiding delays, and staying inspection-ready without overbuilding internal structures.

    立即观看

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.